We wished to determine whether subtotal replacement of protein in plasma removed at plasma exchange would be adequate to prevent hypovolemia and hypoproteinemia. Seven well nourished outpatients with chronic progressive multiple sclerosis underwent 60 plasma exchanges in which two liters of plasma w
Succinylated gelatin as partial fluid replacement in chronic therapeutic plasma exchange
β Scribed by Sue Gregor-MacGregor; Dr. Charles D. Pusey
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 153 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Human albumin is commonly used as a replacement fluid in therapeutic plasma exchange (pe). in order to determine whether pentaspan (pes), a synthetic low molecular weight starch solution, might be an effective substitute, we compared albumin with pes in 12 patients with myasthenia gr
## Abstract Therapeutic plasma exchange (TPE) is an effective treatment in Myasthenia gravis (MG) and GuillainβBarrΓ© syndrome (GBS) and 5% human albumin is the replacement fluid of choice; however, it is expensive. More recently, it has been suggested that starch is a safe and cheaper choice to hum
We compared the safety, effect on plasma proteins, and contribution to hypocalcemic toxicity of 10% pentastarch vs. 5% albumin in plasma exchange. Thirty-two neurology patients underwent 161 plasma exchange procedures. Subjects were randomized to receive either 10% pentastarch (n β«Χ‘β¬ 17) or 5% album